NLRP3 and atherosclerosis: Recent studies have highlighted hsCRP’s role in activating the NLRP3 inflammasome in endothelial cells, linking it to LDL transcytosis and atherosclerosis progression through reactive oxygen species (ROS) regulation and inflammasome activation [35,36].